[Thrombotic microangiopathy as a rare complication after lung transplantation]

Mehmet Can Sayar1, Laura Pott2, Stephanie Damm3

  • 1Klinik für Pneumologie, Universitätsspital Zürich, Zürich.

Praxis
|November 12, 2024
PubMed
Abstract

Insights

Atypical hemolytic-uremic syndrome (aHUS) is a rare condition causing organ damage. This case highlights the challenges of diagnosing and managing aHUS in lung transplant recipients.

Area of Science:

  • Nephrology
  • Transplant Medicine
  • Hematology

Background:

  • Thrombotic microangiopathy (TMA) presents with thrombocytopenia, hemolytic anemia, and organ dysfunction due to microthrombi.
  • TMA encompasses thrombotic thrombocytopenic purpura (TTP), Shiga toxin-induced hemolytic uremic syndrome (STEC-HUS), secondary TMA, and atypical hemolytic uremic syndrome (aHUS).

Purpose of the Study:

  • To present a unique case of atypical hemolytic-uremic syndrome (aHUS) in a lung transplant recipient.
  • To illustrate the complexities in diagnosing and managing TMA in the post-transplant setting.

Main Methods:

  • Case report of a 49-year-old lung transplant recipient.
  • Review of diagnostic challenges and management strategies for TMA and aHUS.

Main Results:

  • The patient developed aHUS post-lung transplantation.
  • The case underscores the difficulties in differentiating TMA subtypes and managing aHUS in immunocompromised patients.

Conclusions:

  • Atypical hemolytic-uremic syndrome (aHUS) poses significant diagnostic and therapeutic challenges in lung transplant recipients.
  • Early recognition and tailored management are crucial for improving outcomes in post-transplant TMA.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...